Congruence secures a $5 million grant to advance innovative therapies for GBA1 Parkinson's disease, enhancing hope for ...

The acquisition led by Advent International will see the two AI-powered companies combine forces to improve the healthcare ...

The side effects that come with many cancer treatments can cause people to delay or avoid treatment.

Unlock the secrets of executive presence in pharma to inspire confidence, influence decisions, and elevate your leadership ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Emrelis is accelerating investor interest, validating biomarker-driven ADCs, and shaping distinct strategic ...

Global leader in mother and childcare, Philips Avent, announced a partnership with March of Dimes to establish the modern-day ...

Copycats and false advertisements are also to blame for the increased threats. Stemming from social media testimonials all ...

Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, highlights Emrelis’ potential to broaden its clinical impact ...

A timeline of key developments surrounding Sarepta Therapeutics' Duchenne muscular dystrophy drug Elevidys, and the potential ...

According to the terms of the agreement, Sanofi will acquire London-based Vicebio’s entire share capital for an upfront ...

A special live broadcast of award-winning star and CEO’s conversation will focus on advancements and regulations on ALS ...

Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...